Addus HomeCare Corporation (ADUS) - Stock Analysis

Last updated: Apr 26, 2026

HealthcareClosed

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.

Loading chart data...

Idea window: 10/20/2025 – 10/27/2025Sector: Healthcare

AI Analyst Overview

Last Price
$99.29
Market Cap
$1.83B
1D Return
+1.17%
YTD Return
-7.54%

Loading chart data...

Valuation Metrics

P/E
18.9
P/B
1.7
P/S
1.3
EV/EBITDA
12.8
Div Yield
—

Fundamental Analysis

7.0

Key Financial Insights: • Strong margins • Solid liquidity • Intangible-heavy equity ADUS shows strong profitability, solid liquidity, and modest leverage with good cash generation, but its premium valuation and intangible-heavy balance sheet suggest the stock already reflects much of the quality.

Quality
Valuation

Price Behavior

5.0

Key Price Behavior Insights: • Higher lows • Resistance capped • Support holding Support Level: $93.0 / $91.5 Resistance Level: $97.7–$100.0 ADUS has stabilized off its early-April low and is making higher lows, but it remains in a short-term downtrend under the key $97.7–$100 resistance zone, so a close above that band would improve the outlook while a break below $93 would weaken it.

ADUS
bullish

Sentiment & News

4.0

Key News Insights: • 52-week low • Mixed ownership • Earnings catalyst Addus HomeCare is trading under pressure near 52-week lows, but the upcoming Q1 2026 earnings report on May 4 could be the key catalyst to clarify whether recent weakness is temporary or fundamental.

ADUS
earnings
AI

AI Summary

6.0
Neutral

ADUS now looks like a high-quality operator with strong cash generation, low leverage, and solid execution, but the investment case hinges on whether it can sustain margins and avoid a valuation hit as Medicare/home health reimbursement risk and weak sentiment pressure the stock.

Quality
ReimbursementRisk
Valuation
AI summary updated 2 days ago

Description

Addus HomeCare provides in-home personal care, hospice, and home health services to elderly, chronically ill, disabled people and those at risk of hospitalization in the United States. Its Personal Care unit supplies non-medical assistance with daily living activities, the Hospice unit delivers palliative and family support services, and the Home Health unit offers skilled nursing and rehabilitative therapies. The company contracts with government programs, managed care organizations, commercial insurers and private clients, and as of December 31, 2021 operated 206 offices in 22 states; it was founded in 1979 and is based in Frisco, Texas.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Oct 20Oct 27ADUSAddus HomeCare Corporation
Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.
Closed+0.0%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.